MedPath

safety test in luteoli

Phase 1
Recruiting
Conditions
prostate cancer patients
Registration Number
JPRN-jRCTs041210142
Lead Sponsor
aiki-Ito Aya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
5
Inclusion Criteria

1)newly diagnosed, or recurrence after radical treatment but slowly progression in PSA in low risk patients
2)initial PSA < 10ng/mL, and cT2, orrecurrence after radical treatment but slowly progressed 0.05ng/mL per year in PSA
3)patients with informed consent in this research
4) male patients older than 20
5)patients with less than ECOG PS 1

Exclusion Criteria

patients in dementia
patients with severe infection
patients with hepatic dysfunction
patients with renal disorders
patients who was recognized as inadequate in this test by doctors

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
incidence and severity in adverse events
Secondary Outcome Measures
NameTimeMethod
PSA or UA response from baseline
© Copyright 2025. All Rights Reserved by MedPath